Technion NANO student leadership. | PRESIDENT’S REPORT 2015

This month welcomes new leadership of the Technion’s Norman Seiden Multidisciplinary Graduate program in Nanoscience & Nanotechnology. Prof. Dror Seliktar of the Department of Biomedical Engineering.

http://portal.bm.technion.ac.il/SiteCollectionImages/dror.jpg

Dror Seliktar , Associate Professor

Prof. Seliktar replaces Prof. Yachin Cohen, who headed the dynamic interdisciplinary graduate NANO program since its inception six years ago, has now completed his duties with the Program. Watch Technion RBNI nano students at work in this video!

Prof. Dror Selitka is CSO and Co-Founder of Regentis Biomaterials

Established in 2004, Regentis Biomaterials is a tissue repair company that is developing and commercializing innovative biodegradable hydrogels for the local repair of damaged cartilage and bone.
Our platform technology is a family of hydrogels called Gelrin™. These gels can be injected or applied to a specific local site and offer beneficial properties for the local repair of damaged tissue such as cartilage and bone.
The Gelrin™ technology offers off-the-shelf products that are designed to be suitable for both open surgery and minimally invasive procedures. An ideal solution for physicians and their patients, the products are easy to implant and have been shown to stimulate the regeneration of healthy cartilage and bone tissue.
Regentis’ first orthopedic product is GelrinC, a biodegradable hydrogel for articular cartilage regeneration. Additional pipeline products include GelrinB – a biodegradable hydrogel for bone regeneration; and GelrinA – a void filling matrix for aesthetic indications.